Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
13F holders, Q2 2026
Institutional positions in Aclarion, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +5 vs. Q1 2026
- Shares held
- 115.3K
- +2.75K (+2.4%) vs. Q1 2026
- Total value
- $332.1K
- −$36.0K (−9.8%) vs. Q1 2026
- New holders
- 7
- 2 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $332.1K |
| Q1 2026 | 10 | $368.1K |
| Q4 2025 | 8 | $80.2K |
| Q3 2025 | 8 | $168.0K |
| Q2 2025 | 5 | $13.7K |
| Q1 2025 | 6 | $734 |
| Q4 2024 | 9 | $66.4K |
| Q3 2024 | 9 | $68.4K |
| Q2 2024 | 9 | $94.2K |
| Q1 2024 | 7 | $89.4K |
| Q4 2023 | 9 | $124.0K |
| Q3 2023 | 9 | $175.9K |
| Q2 2023 | 13 | $423.6K |
| Q1 2023 | 8 | $114.0K |
| Q4 2022 | 5 | $19.2K |
| Q3 2022 | 9 | $123.0K |
| Q2 2022 | 3 | $66.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aclarion, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 19,480 | $56.1K | 0.00% | +19,480 | New |
| Captrust Financial Advisors | 17,059 | $49.1K | 0.00% | +2,500+17.2% | Added |
| Vanguard Fiduciary Trust Co | 16,028 | $46.2K | 0.00% | +16,028 | New |
| Susquehanna International Group, LLP | 15,355 | $44.2K | 0.00% | +15,355 | New |
| Geode Capital Management, LLC | 12,128 | $34.9K | 0.00% | −19,087−61.1% | Reduced |
| XTX Topco Ltd | 11,038 | $31.8K | 0.00% | +11,038 | New |
| Bank of Montreal | 10,000 | $28.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 6,782 | $19.5K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5,000 | $14.4K | 0.00% | −29,945−85.7% | Reduced |
| UBS Group AG | 1,968 | $5.67K | 0.00% | −7,679−79.6% | Reduced |
| Barclays PLC | 283 | $815 | 0.00% | +283 | New |
| Clear Street Group Inc. | 103 | $297 | 0.00% | +100+3,333.3% | Added |
| Wells Fargo & Company | 100 | $288 | 0.00% | +100 | New |
| Caitong International Asset Management Co., Ltd | 4 | $12 | 0.00% | +4 | New |
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −5,422−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |